The United States does not approve pet grooming sprays before sale, and that absence of pre-market review is widely misread as an absence of rules. What actually governs a pet deodorant spray is a set of scope tests: is the product a cosmetic, a drug, a pesticide, or a consumer product? Each answer brings a different regulator, a different label obligation and a different failure mode. This guide sets out the tests in the order that matters, and corrects the most common misconception about MoCRA.
Start With Scope, Not With Paperwork
Every US compliance question about a pet spray resolves to one prior question: what is the product, in law? The Federal Food, Drug, and Cosmetic Act defines a cosmetic by its intended use on the human body - articles applied to cleanse, beautify or alter appearance. A spray for a dog's coat is not applied to a human body, so it is not a cosmetic under that definition, and the cosmetic framework does not attach to it simply because it is sold next to shampoo.
The product is instead, in the ordinary case, a consumer product: a household article sold to consumers, subject to the Consumer Product Safety Act and, where it carries a hazard, to the Federal Hazardous Substances Act's cautionary labelling requirements. Advertising is separately governed by the prohibition on deceptive claims. Import is governed by customs and by the Consumer Product Safety Commission's import enforcement.
That framing is not a technicality. It tells you which documents a retailer will ask for, which claims will trigger a different regulator, and why a supplier who offers an FDA registration number as proof of compliance is answering a question you did not ask.
MoCRA: What It Covers, and Why It Does Not Cover Your Pet Spray
The Modernization of Cosmetics Regulation Act of 2022 is the most significant change to US cosmetic law in decades. It introduced mandatory facility registration, product listing with ingredient identifiers, serious adverse event reporting and records access, plus authority to establish GMP rules. The obligations are real and enforcement is live.
They also apply to cosmetics - products for human use. A pet deodorant spray is not within that definition, so MoCRA facility registration and product listing do not attach to it, and a supplier's FEI number is not evidence of compliance for a pet SKU. The misconception is widespread in sourcing conversations, and it produces two expensive errors: paying for registration the product does not need, and assuming a registration file implies a compliant product.
MoCRA becomes relevant in three situations. You also sell a human-use cosmetic, such as a hand sanitiser or a grooming product for people, in which case MoCRA governs that line. A contract manufacturer runs both human cosmetic and pet lines, in which case its registrations tell you something about the site's systems even though they do not cover your product. Or your retailer applies a vendor standard that imports cosmetic-style documentation as a condition of listing, which is a commercial requirement rather than a legal one.
The Claim Boundary That Moves You to Another Regulator
For a pet product, claims do more work than category. A spray described as freshening the coat, reducing odour or cleansing the paws stays a consumer product. Introduce a claim to treat or prevent disease, to control a parasite, or to act against micro-organisms in a way that implies a health outcome, and the product can become an animal drug under the FD&C Act, regulated by the FDA's Center for Veterinary Medicine, with consequences that include establishment registration, listing and, for new animal drugs, an approval pathway.
Repellent and insecticidal positioning moves in a different direction, toward the Environmental Protection Agency and FIFRA, which requires registration of the pesticide and of the establishment that produces it. This is why a 'natural flea repellent' is one of the most expensive sentences a brand can put on a label, and why the wording has to be reviewed before the formula is finalised. Our guide to repellent spray positioning walks through that boundary in detail.
The table below is the scope matrix we use at brief stage. It is deliberately blunt: the point is to force the decision early, when reformulating or rewording costs a week rather than a container.
| Framework | What triggers it | Core obligation | Practical consequence |
|---|---|---|---|
| Consumer Product Safety Act / FHSA | Any household consumer product; hazard-based warning duties | Substantially safe product, cautionary labelling where hazardous, defect reporting | Consumer product default; retailer vendor standards apply |
| FD&C Act - cosmetic provisions and MoCRA | Product intended for the human body | Facility registration, product listing, adverse event reporting | Does not attach to a pet spray; relevant only to a human-use line |
| FD&C Act - animal drug provisions | Claim to treat, cure, mitigate or prevent disease | New animal drug approval pathway; establishment registration and listing | Claim change reclassifies the product and the timeline |
| FIFRA | Pesticidal or repellent claim, including insect or parasite control | Pesticide registration and producing establishment registration | Registration precedes sale; label must match the registration |
| FPLA and state consumer rules | Consumer commodity sold at retail with a net quantity statement | Accurate net quantity, identity, responsible party disclosure | Label review; California Proposition 65 exposure for listed substances |
Source: U.S. FDA Center for Veterinary Medicine and FDA cosmetics programme documentation; EPA FIFRA materials; 15 U.S.C. consumer product statutes. Confirm classification with US regulatory counsel before printing labels.
Labeling: What Is Actually Required
There is no pet-specific cosmetic label statute, so the label is built from several overlapping sources. The Fair Packaging and Labeling Act and state unit-pricing rules require an accurate net quantity, typically declared in both US customary and metric units. If the product is a hazardous substance within the FHSA - and an aerosol or a concentrated surfactant system often can be - cautionary statements on signal word, hazards and first aid become mandatory and have content rules.
On top of that sit the requirements buyers impose. Specialty retail and marketplaces expect a full ingredient declaration in INCI order, a batch or lot code, an identity statement, a responsible party with a US address and a country of origin statement on imports. None of that is a pet-product statute; all of it is a listing condition, and a missing lot code will hold a shipment faster than a legal argument will release it.
Two label traps recur. First, net quantity must be accurate at fill, not at nominal - over-declaring volume to look competitive is a compliance and a customer-service problem. Second, warnings must match the hazard communication file, because an SDS that lists eye irritation while the label says nothing invites a claim that the manufacturer knew and stayed silent.
| Element | Legal basis | Checked by |
|---|---|---|
| Identity statement | FPLA and state consumer protection practice | Retail compliance team, marketplace listing review |
| Net quantity in US customary and metric | FPLA, state unit pricing rules | Retail receiving and listing audit |
| Responsible party with US address | Consumer product practice; retailer standard | Importer and retailer vendor onboarding |
| Ingredient declaration in INCI order | Not mandated for pet products as such; expected by buyers | Retail category buyer, marketplace |
| Hazard warnings and first aid | FHSA where the product is a hazardous substance | Regulatory reviewer; insurer |
| Batch or lot code | Traceability practice; retailer contract | Quality team, recall drill |
| Country of origin | Customs marking requirements for imports | Importer of record, customs broker |
Source: U.S. Consumer Product Safety Commission statute and FHSA labelling requirements; Fair Packaging and Labeling Act; retailer vendor standards as observed in export projects.
Safety, Substantiation and the Duty That Survives No Pre-Market Review
No pre-market approval does not mean no duty. A consumer product must be substantively safe for its intended use, and a defect that creates a substantial product hazard triggers reporting obligations to the Consumer Product Safety Commission.
Practical compliance therefore looks like a technical file rather than a certificate: formulation and raw-material specifications, safety data sheets in the destination format, stability and microbiological data, a use and exposure rationale that accounts for licking and grooming, and batch traceability that can support a recall. Claims need their own evidence - this is where hypoallergenic and similar claim wording becomes a documentation exercise rather than a marketing one.
For brands selling into both blocs, the useful discipline is a single technical file that feeds US, EU and UK requirements, with a market overlay for label text and claims. Our UK compliance walkthrough shows how much of that overlay diverges after Brexit, and the fragrance allergen guidance covers the declaration questions that a US label usually omits and a European label cannot.
State Rules and Channel Requirements
State law is where a national launch acquires its first surprise. California Proposition 65 requires a clear and reasonable warning for listed chemicals above stated exposure levels, and it is enforced through private actions, so private plaintiffs rather than an agency set the pace. Formulations containing certain preservatives, residual solvents or trace heavy metals need a review against the list, and fragrance components deserve specific attention.
Beyond that, states apply their own consumer protection statutes to advertising, and several operate active ingredient disclosure or cosmetic reporting programmes that can reach a product if the brand also sells personal care. The practical approach is to review California, New York and Illinois early if national distribution is the goal, and to treat the retailer's vendor standard as a fourth rulebook: Amazon, Chewy and the larger chains each publish documentation requirements that exceed the legal minimum, and they enforce them by removing listings.
A Practical US Launch Sequence
The sequence that avoids rework starts with the claim set and works backwards to the formula. Fix the intended use and the claim wording, classify the product against the scope matrix, then confirm which label obligations follow and which documents the importer and the retailer will demand. Only then finalise the formula, because a claim change can force a reformulation and a new stability run.
Then verify the supply chain documents rather than the supplier's assurances: a specification, a safety data sheet in English in the destination format, a certificate of analysis per lot, stability data at the claimed shelf life, and an ingredient disclosure complete enough to build both labels. If the brand is the importer of record, budget for the customs classification and for a US agent or responsible address, because both are operational facts that appear on the label and in the listing. Our regulatory team reviews claim sets and label overlays against these four frameworks before artwork is released.
- Lock the claim set and classify the product before formulation
- Confirm whether any claim triggers animal drug or FIFRA registration
- Build one technical file that can serve US, EU and UK overlays
- Match label warnings to the safety data sheet
- Review California Proposition 65 for preservatives, solvents and fragrance
- Collect lot-level COA and traceability before the first shipment
Frequently Asked Questions
Do pet deodorant sprays need FDA approval before sale?
No. A pet grooming spray that makes no drug or pesticide claim is a consumer product and is not approved or registered with the FDA before sale. The absence of pre-market review does not remove the duty to make a safe product with accurate labelling. If the product claims to treat or prevent disease, it can become an animal drug under the FD&C Act, and then an approval pathway and establishment requirements apply.
Does MoCRA facility registration apply to pet products?
No. MoCRA amended the cosmetic provisions of the FD&C Act, and those provisions are written around products intended for the human body. Facility registration, product listing and cosmetic adverse event reporting therefore do not attach to a pet spray. A supplier's FEI number or registration file is not evidence of compliance for a pet SKU. It is relevant only if the brand or the site also handles human-use cosmetics.
Can I say the spray kills 99.9% of bacteria?
Not on a consumer product without registration. A claim that the product kills micro-organisms is pesticidal or drug-like depending on the wording and the intended use, which brings either FIFRA registration with the EPA or animal drug requirements with the FDA. Rewrite the claim around cleaning and odour removal, which the product can support with formulation and removal data, and keep any antimicrobial language out of both the label and the product page.
What labelling is legally required on a US pet spray?
There is no pet-specific cosmetic label statute, so obligations come from several sources: an accurate net quantity under the Fair Packaging and Labeling Act, hazard warnings and first aid under the Federal Hazardous Substances Act where the product is hazardous, country of origin marking for imports, and state consumer protection rules that prohibit misleading statements. Most retailers then require an INCI ingredient list, a lot code and a US responsible address as listing conditions.
Who is responsible for compliance when the product is made overseas?
Responsibility does not move offshore with production. The brand placing the product on the US market holds the compliance position, and the importer of record holds the customs and safety duties. That means the brand must be able to produce the technical file, the safety data sheet, lot traceability and claim substantiation on request. A supplier who will not give you those documents in your own name is a supply chain risk, not just a paperwork inconvenience.
How should Proposition 65 be handled for a fragrance-containing spray?
Review the fragrance declaration and the full formula against the Proposition 65 list, then decide between reformulating, warning, or holding exposure evidence that a warning is not required. Because the statute is enforced largely through private actions, the analysis has to be documented rather than assumed. Practically, ask the fragrance house for a Proposition 65 statement per compound and keep it with the batch records rather than in a marketing folder.
Conclusion
US entry for a pet spray is not a registration exercise; it is a classification exercise. Decide whether the product is a consumer product, an animal drug or a pesticide, and most of the remaining questions answer themselves, including which regulator, which label elements and which documents the importer will demand. The two costly errors are paying for cosmetic registration the product does not need, and letting a therapeutic claim slip into the copy and reclassify the whole project. Settle scope, claims and label together, keep the technical file in your own name, and the launch becomes a sequence of known steps rather than a series of surprises.
